Reqorsa is a targeted therapy designed to address specific genetic mutations in advanced cancers, particularly non-small cell lung cancer. By inhibiting tumor growth at the molecular level, it offers a precision medicine option when standard treatments fail. Patients with confirmed biomarkers benefit most, using it as a daily oral treatment under oncologist guidance to potentially extend progression-free survival.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends